by editor | Jun 12, 2014 | Blog, Featured, StockGuru, StockGuru Blog, Trade Alert, Update
Brainstorm Cell Therapeutics (OTCQB: BCLI) continues to be on fire. Trading today represented the highest dollar volume for the year and the second highest share volume for the year. With over 4 million shares traded, the stock has just crossed into the highest...
by editor | Jan 23, 2013 | Asides, Blog
BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that its CEO, Dr. Adrian Harel, has issued an Annual Letter to Shareholders summarizing the company’s extremely significant...
by editor | Oct 12, 2010 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Brainstorm Cell Therapeutics Inc. (OTCBB: BCLI) is in the StockGuru Spotlight. BrainStorm Cell Therapeutics Inc. is an emerging company developing adult stem cell therapeutic products, derived from autologous (self) bone...
